Advertisement
ATRA vs AUTL
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a StrongBuy and AUTL is a Hold.
ATRA in upward trend: 10-day moving average moved above 50-day moving average on October 13, 2026
The 10-day moving average for ATRA crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 63 cases where ATRA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on ATRA as a result. In 74 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for ATRA just turned positive on October 21, 2026. Looking at past instances where ATRA's MACD turned positive, the stock continued to rise in 41 of 48 cases over the following month. The odds of a continued upward trend are 85%.
ATRA moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRA advanced for three days, in 231 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
ATRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for ATRA entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.559) is normal, around the industry mean (2.973). P/E Ratio (-6.163) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (22.883) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ATRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
AUTL in downward trend: 10-day moving average moved below 50-day moving average on September 22, 2026
The 10-day moving average for AUTL crossed bearishly below the 50-day moving average on September 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AUTL as a result. In 61 of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
AUTL moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AUTL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for AUTL entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AUTL's RSI Oscillator exited the oversold zone, 23 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where AUTL advanced for three days, in 223 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
AUTL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. AUTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.619) is normal, around the industry mean (2.973). P/E Ratio (-1.491) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (4.228) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AUTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ATRA | AUTL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 7 | 69 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | 73 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 99 | |
PRICE GROWTH RATING 1..100 | 40 | 58 | |
P/E GROWTH RATING 1..100 | 97 | 57 | |
SEASONALITY SCORE 1..100 | 50 | 7 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ATRA's Valuation (16) in the Biotechnology industry is somewhat better than the same rating for AUTL (73). This means that ATRA’s stock grew somewhat faster than AUTL’s over the last 12 months.
ATRA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AUTL (100). This means that ATRA’s stock grew similarly to AUTL’s over the last 12 months.
AUTL's SMR Rating (99) in the Biotechnology industry is in the same range as ATRA (100). This means that AUTL’s stock grew similarly to ATRA’s over the last 12 months.
ATRA's Price Growth Rating (40) in the Biotechnology industry is in the same range as AUTL (58). This means that ATRA’s stock grew similarly to AUTL’s over the last 12 months.
AUTL's P/E Growth Rating (57) in the Biotechnology industry is somewhat better than the same rating for ATRA (97). This means that AUTL’s stock grew somewhat faster than ATRA’s over the last 12 months.
| ATRA | AUTL | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 77% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 86% |
| MACD ODDS (%) | 1 day ago 85% | N/A |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 87% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 85% |
| Advances ODDS (%) | 1 day ago 86% | 8 days ago 86% |
| Declines ODDS (%) | 4 days ago 86% | 1 day ago 88% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 89% |
| Aroon ODDS (%) | 1 day ago 89% | 1 day ago 80% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ATRA’s FA Score shows that 1 FA rating(s) are green while AUTL’s FA Score has 0 green FA rating(s).
- ATRA’s FA Score: 1 green, 4 red.
- AUTL’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ATRA’s TA Score shows that 6 TA indicator(s) are bullish while AUTL’s TA Score has 4 bullish TA indicator(s).
- ATRA’s TA Score: 6 bullish, 3 bearish.
- AUTL’s TA Score: 4 bullish, 5 bearish.
Price Growth
ATRA (@Biotechnology) experienced а -2.28% price change this week, while AUTL (@Biotechnology) price change was -4.14% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.
Reported Earning Dates
ATRA is expected to report earnings on Nov 11, 2026.
AUTL is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Biotechnology (-1.17% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ATRA and
Correlation & Price change
A.I.dvisor indicates that over the last year, ATRA has been loosely correlated with PHAT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRA jumps, then PHAT could also see price increases.
| Ticker / NAME | Correlation To ATRA | 1D Price Change % | ||
|---|---|---|---|---|
| ATRA | 100% | +0.86% | ||
| PHAT - ATRA | 36% Loosely correlated | -0.28% | ||
| LXEO - ATRA | 33% Loosely correlated | -3.67% | ||
| INVA - ATRA | 33% Poorly correlated | +0.72% | ||
| AUTL - ATRA | 31% Poorly correlated | -2.47% | ||
| MOLN - ATRA | 31% Poorly correlated | +3.31% | ||
More | ||||
AUTL and
Correlation & Price change
A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with CRSP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then CRSP could also see price increases.
| Ticker / NAME | Correlation To AUTL | 1D Price Change % | ||
|---|---|---|---|---|
| AUTL | 100% | -2.47% | ||
| CRSP - AUTL | 47% Loosely correlated | -1.01% | ||
| RCKT - AUTL | 42% Loosely correlated | +5.00% | ||
| VIR - AUTL | 42% Loosely correlated | -1.32% | ||
| TSHA - AUTL | 41% Loosely correlated | -2.79% | ||
| RXRX - AUTL | 41% Loosely correlated | -1.65% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VMAX | 66.44 | 2.37 | +3.70% |
| Hartford US Value ETF (VMAX) | |||
| BRW | 5.89 | 0.04 | +0.68% |
| Saba Capital Income & Opportunities Fund | |||
| CORN | 17.78 | -0.20 | -1.11% |
| Teucrium Corn Fund (CORN) | |||
| QDPL | 45.88 | -0.54 | -1.16% |
| Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF (QDPL) | |||
| LDEM | 56.99 | -1.50 | -2.56% |
| iShares ESG MSCI EM Leaders ETF (LDEM) | |||